These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2725060)

  • 1. Monoclonal antibody M195: a diagnostic marker for acute myelogenous leukemia.
    Scheinberg DA; Tanimoto M; McKenzie S; Strife A; Old LJ; Clarkson BD
    Leukemia; 1989 Jun; 3(6):440-5. PubMed ID: 2725060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restricted expression of an early myeloid and monocytic cell surface antigen defined by monoclonal antibody M195.
    Tanimoto M; Scheinberg DA; Cordon-Cardo C; Huie D; Clarkson BD; Old LJ
    Leukemia; 1989 May; 3(5):339-48. PubMed ID: 2716349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the individual and combined reactivities of monoclonal antibodies H25, H366, and MY9 with normal progenitor cells and blast cells from patients with acute myeloblastic leukemia.
    Wisniewski D; Strife A; Arlin Z; Knowles R; Lambek C; Gulati S; McHendry B; McKenzie S; Clarkson B
    Leukemia; 1989 Jun; 3(6):446-52. PubMed ID: 2657231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological and immunological features of humanized M195 (anti-CD33) monoclonal antibodies.
    Caron PC; Co MS; Bull MK; Avdalovic NM; Queen C; Scheinberg DA
    Cancer Res; 1992 Dec; 52(24):6761-7. PubMed ID: 1458463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiolabeled anti-CD33 monoclonal antibody M195 for myeloid leukemias.
    Jurcic JG; Caron PC; Nikula TK; Papadopoulos EB; Finn RD; Gansow OA; Miller WH; Geerlings MW; Warrell RP; Larson SM
    Cancer Res; 1995 Dec; 55(23 Suppl):5908s-5910s. PubMed ID: 7493368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-CD33 monoclonal antibody and etoposide/cytosine arabinoside combinations for the ex vivo purification of bone marrow in acute nonlymphocytic leukemia.
    Stiff PJ; Schulz WC; Bishop M; Marks L
    Blood; 1991 Jan; 77(2):355-62. PubMed ID: 1985700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase 1B trial of humanized monoclonal antibody M195 (anti-CD33) in myeloid leukemia: specific targeting without immunogenicity.
    Caron PC; Jurcic JG; Scott AM; Finn RD; Divgi CR; Graham MC; Jureidini IM; Sgouros G; Tyson D; Old LJ
    Blood; 1994 Apr; 83(7):1760-8. PubMed ID: 8142644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine and humanized constructs of monoclonal antibody M195 (anti-CD33) for the therapy of acute myelogenous leukemia.
    Caron PC; Schwartz MA; Co MS; Queen C; Finn RD; Graham MC; Divgi CR; Larson SM; Scheinberg DA
    Cancer; 1994 Feb; 73(3 Suppl):1049-56. PubMed ID: 8306247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells.
    Griffin JD; Linch D; Sabbath K; Larcom P; Schlossman SF
    Leuk Res; 1984; 8(4):521-34. PubMed ID: 6590930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody.
    Ball ED; Graziano RF; Fanger MW
    J Immunol; 1983 Jun; 130(6):2937-41. PubMed ID: 6574189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reactivity of a novel monoclonal antibody ZCH-2B8a on normal hematopoietic cells and malignant cell lines and its significance].
    Tang YM; Guo L; Yang SL; Shen HQ; Qian BQ; Zhang Y; Zhang HZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct; 14(5):990-4. PubMed ID: 17096904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal expression of N-CAM (CD56) adhesion molecule on myeloid and progenitor cells from chronic myeloid leukemia.
    Lanza F; Bi S; Castoldi G; Goldman JM
    Leukemia; 1993 Oct; 7(10):1570-5. PubMed ID: 7692192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclide.
    Scheinberg DA; Lovett D; Divgi CR; Graham MC; Berman E; Pentlow K; Feirt N; Finn RD; Clarkson BD; Gee TS
    J Clin Oncol; 1991 Mar; 9(3):478-90. PubMed ID: 1999719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic phenotype of chronic granulocytic leukaemia progenitor cells in chronic phase and in blastic transformation characterized by means of monoclonal antibodies.
    Robak T
    Arch Immunol Ther Exp (Warsz); 1988; 36(4):471-85. PubMed ID: 3074744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humanized M195 monoclonal antibody conjugated to recombinant gelonin: an anti-CD33 immunotoxin with antileukemic activity.
    Pagliaro LC; Liu B; Munker R; Andreeff M; Freireich EJ; Scheinberg DA; Rosenblum MG
    Clin Cancer Res; 1998 Aug; 4(8):1971-6. PubMed ID: 9717827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-escalation trial of M195 labeled with iodine 131 for cytoreduction and marrow ablation in relapsed or refractory myeloid leukemias.
    Schwartz MA; Lovett DR; Redner A; Finn RD; Graham MC; Divgi CR; Dantis L; Gee TS; Andreeff M; Old LJ
    J Clin Oncol; 1993 Feb; 11(2):294-303. PubMed ID: 8426207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4 predicts nonlymphocytic lineage in acute leukemia. Insights from analysis of 125 cases using two-color flow cytometry.
    Larson RS; McCurley TL
    Am J Clin Pathol; 1995 Aug; 104(2):204-11. PubMed ID: 7543728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terminal deoxynucleotidyl transferase positive subpopulations occur in the majority of ANLL: implications for the detection of minimal disease.
    Adriaansen HJ; van Dongen JJ; Kappers-Klunne MC; Hählen K; van 't Veer MB; Wijdenes-de Bresser JH; Holdrinet AC; Harthoorn-Lasthuizen EJ; Abels J; Hooijkaas H
    Leukemia; 1990 Jun; 4(6):404-10. PubMed ID: 2359340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of myeloid leukemias with monoclonal antibodies 3C5 and MY9.
    Matutes E; Rodriguez B; Polli N; Tavares de Castro J; Parreira A; Andrews C; Griffin JD; Tindle RW; Catovsky D
    Hematol Oncol; 1985; 3(3):179-86. PubMed ID: 3862640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-producing human-human hybridomas. III. Derivation and characterization of two antibodies with specificity for human myeloid cells.
    Andreasen RB; Olsson L
    J Immunol; 1986 Aug; 137(3):1083-90. PubMed ID: 3459756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.